Fluorescence lifetime of actin in the familial hypertrophic cardiomyopathy transgenic heart

Biochemistry

Volumn 48, Issue 6, 2009, Pages 1264-1271

  Mettikolla, P ^a   Luchowski, R ^a,b   Gryczynski, I ^a,c   Gryczynski, Z ^a   Szczesna Cordary, D ^d   Borejdo, J ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^c UNIVERSITY OF NORTH TEXAS   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVERAGE RATES; CLINICAL STUDIES; CROSS BRIDGES; DUTY CYCLES; DUTY RATIOS; ENVIRONMENTAL FACTORS; FAMILIAL HYPERTROPHIC CARDIOMYOPATHIES; FLUORESCENCE LIFE-TIME; FLUORESCENT SPECIES; INDEPENDENT MEASUREMENTS; ISOMETRIC CONTRACTIONS; MYOFIBRILS; PHALLOIDIN; REGULATORY LIGHT CHAINS; THIN FILAMENTS; TRANSGENIC; TURNOVER RATES;

FLUORESCENCE; PLANTS (BOTANY); SHRINKAGE;

MUSCLE;

PHALLOIDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FLUORESCENCE; MUSCLE CONTRACTION; MUSCLE FIBRIL; MUSCLE ISOMETRIC CONTRACTION; MUSCLE RELAXATION; MUTATION; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ACTINS; ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; FLUORESCENCE; HEART; MICE; MICE, TRANSGENIC; MICROFILAMENTS; MYOCARDIAL CONTRACTION; MYOFIBRILS; PHALLOIDINE; RIGOR MORTIS; TIME FACTORS;

MUS MUSCULUS;

EID: 64349087486     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi801629d     Document Type: Article

References (32)

1. Heineke, J., and Molkentin, J. D. (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. ReV. Mol. Cell. Biol. 7, 589-600.
2. Lips, D. J., deWindt, L. J., van Kraaij, D. J. W., and Doevendans, P. A. (2003) Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy. Eur. Heart J. 24, 883-896.
3. Szczesna, D. (2003) Regulatory light chains of striated muscle myosin. Structure, function and malfunction. Curr. Drug Targets: CardioVasc. & Haematol. Disord. 3, 187-197.
4. Alcalai, R., Seidman, J. G., and Seidman, C. E. (2008) Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J. CardioVasc. Electrophysiol. 19, 104-110.
5. Maron, B. J. (2002) The young competitive athlete with cardiovascular abnormalities: causes of sudden death, detection by preparticipation screening, and standards for disqualification. Card. Electrophysiol. Rev. 6, 100-103.
6. Maron, B. J., Olivotto, I., Spirito, P., Casey, S. A., Bellone, P., Gohman, T. E., Graham, K. J., Burton, D. A., and Cecchi, F. (2000) Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 102, 858-864.
7. Richard, P., Charron, P., Carrier, L., Ledeuil, C., Cheav, T., Pichereau, C., Benaiche, A., Isnard, R., Dubourg, O., Burban, M., Gueffet, J.-P., Millaire, A., Desnos, M., Schwartz, K., Hainque, B., and Komajda, M. (2003) Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy and for the EUROGENE Heart Failure Project. Circulation 107, 2227-2232.
8. Huxley, A. F. (1957) A hypothesis for the mechanism of contraction of muscle. Prog. Biophys. Biophys. Chem. 7, 255-318.
9. Reedy, M. C. (2000) Visualizing myosin's power stroke in muscle contraction. J. Cell Sci. 113 (20), 3551-3562.
10. Sweeney, H. L., and Houdusse, A. (2004) The motor mechanism of myosin V: insights for muscle contraction. Philos. Trans. R. Soc. London, Ser. B 359, 1829-1841.
11. Takagi, Y., Shuman, H., and Goldman, Y. E. (2004) Coupling between phosphate release and force generation in muscle actomyosin. Philos. Trans. R. Soc. London, Ser. B 359, 1913-1920.
12. Lakowicz, J. R. Principles of Fluorescence Spectroscopy; Springer: Boston, 2006.
13. Garcia, D. I., Lanigan, P., Webb, M., West, T. G., Requejo-Isidro, J., Auksorius, E., Dunsby, C., Neil, M., French, P., and Ferenczi, M. A. (2007) Fluorescence lifetime imaging to detect actomyosin states in mammalian muscle sarcomeres. Biophys. J. 93, 2091-2101.
14. Kerrick, W. G L., Kazmierczak, K., Xu, Y., Jones, M., Wang, Y., and Szczesna-Cordary, D. (2008) Malignant D166V-FHC mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice. FASEB J., in press.
15. Szczesna-Cordary, D., Guzman, G., Zhao, J., Hernandez, O., Wei, J., and Diaz-Perez, Z. (2005) The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice. J. Cell Sci. 118, 3675-3683.
16. 2+ binding of human cardiac myosin regulatory light chain affect cardiac muscle contraction. J. Biol. Chem. 279, 3535-3542.
17. Muthu, P., Talent, J. M., Gryczynski, I., and Borejdo, J. (2008) Cross-Bridge Duty Cycle in Isometric Contraction of Skeletal Myofibrils. Biochemistry 47, 5657-5667.
18. Muthu, P., Gryczynski, I., Gryczynski, Z., Talent, J. M., Akopova, I., and Borejdo, J. (2008) Decreasing photobleaching by silver nanoparticles on metal surfaces: application to muscle myofibrils. J. Biomed. Opt. 13, 014023.
19. Bagshaw, C. R. Muscle Contraction; Chapman & Hall: London, 1982.
20. Herrmann, C., Sleep, J., Chaussepied, P., Travers, F., and Barman, T. (1993) A structural and kinetic study on myofibrils prevented from shortening by chemical cross-linking. Biochemistry 32, 7255-7263.
21. Borejdo, J., Muthu, P., Talent, J., Akopova, I., and Burghardt, T. P. (2007) Rotation of Actin monomers during isometric contraction of skeletal muscle. J. Biomed. Opt. 12, 014013.
22. Herrmann, C., Lionne, C., Travers, F., and Barman, T. (1994) Correlation of ActoS1, myofibrillar, and muscle fiber ATPases. Biochemistry 33, 4148-4154.
23. Lionne, C., Iorga, B., Candau, R., and Travers, F. (2003) Why choose myofibrils to study muscle myosin ATPase? J. Muscle Res. Cell Motil. 24, 139-148.
24. Borejdo, J., Shepard, A., Dumka, D., Akopova, I., Talent, J., Malka, A., and Burghardt, T. P. (2004) Changes in orientation of Actin during contraction of muscle. Biophys. J. 86, 2308-2317.
25. Szczesna, D., and Lehrer, S. S. (1993) The binding of fluorescent phallotoxins to Actin in myofibrils. J. Muscle Res. Cell Motil. 14, 594-597.
26. Ao, X., and Lehrer, S. S. (1995) Phalloidin unzips nebulin from thin filaments in skeletal myofibrils. J. Cell Sci. 108, 3397-3403.
27. Aguirre, R., Gonsoulin, F., and Cheung, H. C. (1986) Interaction of fluorescently labeled myosin subfragment 1 with nucleotides and Actin. Biochemistry 25, 6827-6835.
28. 2+ and ADP: focusing on the auto-oscillation (SPOC). AdV. Exp. Med. Biol. 592, 341-358.
29. De La Cruz, E., and Pollard, T. D. (1994) Transient kinetic analysis of rhodamine phalloidin binding to Actin filaments. Biochemistry 33, 14387-14392.
30. Shepard, A. A., Dumka, D., Akopova, I., Talent, J., and Borejdo, J. (2004) Simultaneous measurement of rotations of myosin, Actin and ADP in a contracting skeletal muscle fiber. J. Muscle Res. Cell Motil. 25, 549-557.
31. Bukatina, A. E., Fuchs, F., and Watkins, S. C. (1996) A study on the mechanism of phalloidin-induced tension changes in skinned rabbit psoas muscle fibres. J. Muscle Res. Cell Motil. 17, 365-371.
32. Prochniewicz-Nakayama, E., Yanagida, T., and Oosawa, F. (1983) Studies on conformation of F-Actin in muscle fibers in the relaxed state, rigor, and during contraction using fluorescent phalloidin. J. Cell Biol. 97, 1663-1667.